Beta Bionics, Inc.

General ticker "BBNX" information:

  • Sector: Health Care
  • Industry: Medical - Devices
  • Capitalization: $695.1M (TTM average)

Beta Bionics, Inc. follows the US Stock Market performance with the rate: 5.4%.

Estimated limits based on current volatility of 6.4%: low 14.65$, high 16.64$

Factors to consider:

  • Total employees count: 423 (+41.0%) as of 2025
  • Countries other than US accounted for 0.0% of revenue in the fiscal year ended 2025-12-31
  • Top business risk factors: Limited operating history, Market acceptance, Regulatory and compliance, Manufacturing issues, Supply chain disruptions
  • Current price 22.7% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [18.54$, 41.86$]
  • 2026-12-31 to 2027-12-31 estimated range: [12.68$, 30.65$]

Similar symbols

Short-term BBNX quotes

Long-term BBNX plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $11.99MM $65.12MM $100.25MM
Operating Expenses $47.84MM $110.38MM $171.93MM
Operating Income $-35.85MM $-45.25MM $-71.68MM
Non-Operating Income $-8.25MM $-9.51MM $-1.52MM
R&D Expense $17.94MM $26.18MM $34.79MM
Income(Loss) $-44.10MM $-54.76MM $-73.20MM
Net Income(Loss)* $-44.10MM $-54.76MM $-73.20MM
Stockholders Equity $-203.10MM $-245.36MM $287.61MM
Inventory $1.25MM $13.32MM $21.72MM
Assets $110.04MM $149.65MM $328.74MM
Operating Cash Flow $-32.45MM $-48.27MM $-50.92MM
Capital expenditure $0.40MM $3.40MM $5.30MM
Investing Cash Flow $-69.69MM $-3.48MM $-162.81MM
Financing Cash Flow $101.03MM $55.62MM $214.87MM
Earnings Per Share** $-1.03 $-1.28 $-1.81

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.